Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins

Bach-Ngan Nguyen, Florian Tieves, Florian G. Neusius, H. Götzke, L. Schmitt, C. Schwarz
{"title":"Numaswitch, a biochemical platform for the efficient production of disulfide-rich pepteins","authors":"Bach-Ngan Nguyen, Florian Tieves, Florian G. Neusius, H. Götzke, L. Schmitt, C. Schwarz","doi":"10.3389/fddsv.2023.1082058","DOIUrl":null,"url":null,"abstract":"The application of long-chained peptides (+30 aa) and relatively short proteins (<300 aa) has experienced an increasing interest in recent years. However, a reliable production platform is still missing since manufacturing is challenged by inherent problems such as mis-folding, aggregation, and low production yields. And neither chemical synthesis nor available recombinant approaches are effective and efficient. This in particular holds true for disulfide-rich targets where the correct isomer needs to be formed. With the technology Numaswitch, we have now developed a biochemical tool that circumvents existing limitations and serves as first production platform for pepteins, hard-to-be-produced peptides and proteins between 30 and 300 amino acids in length, including disulfide-rich candidates. Numaswitch is based on bifunctional Switchtag proteins that force the high-titer expression of pure inclusion bodies and simultaneously assist in the efficient refolding of pepteins into functional pepteins. Here, we demonstrate the successful application of the Numaswitch platform for disulfide-containing pepteins, such as an antimicrobial fusion peptide, a single-chain variable fragment (scFv), a camelid heavy chain antibody fragment (VHH) and the human epidermal growth factor.","PeriodicalId":73080,"journal":{"name":"Frontiers in drug discovery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fddsv.2023.1082058","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The application of long-chained peptides (+30 aa) and relatively short proteins (<300 aa) has experienced an increasing interest in recent years. However, a reliable production platform is still missing since manufacturing is challenged by inherent problems such as mis-folding, aggregation, and low production yields. And neither chemical synthesis nor available recombinant approaches are effective and efficient. This in particular holds true for disulfide-rich targets where the correct isomer needs to be formed. With the technology Numaswitch, we have now developed a biochemical tool that circumvents existing limitations and serves as first production platform for pepteins, hard-to-be-produced peptides and proteins between 30 and 300 amino acids in length, including disulfide-rich candidates. Numaswitch is based on bifunctional Switchtag proteins that force the high-titer expression of pure inclusion bodies and simultaneously assist in the efficient refolding of pepteins into functional pepteins. Here, we demonstrate the successful application of the Numaswitch platform for disulfide-containing pepteins, such as an antimicrobial fusion peptide, a single-chain variable fragment (scFv), a camelid heavy chain antibody fragment (VHH) and the human epidermal growth factor.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Numaswitch,一个高效生产富含二硫化物的肽的生化平台
近年来,人们对长链肽(+30个氨基酸)和相对短的蛋白质(<300个氨基酸)的应用越来越感兴趣。然而,由于制造业受到固有问题的挑战,如错误折叠、聚集和低产量,因此仍然缺乏可靠的生产平台。化学合成和现有的重组方法都不是有效的。这尤其适用于需要形成正确异构体的富含二硫化物的靶标。利用Numaswitch技术,我们现在开发了一种生化工具,该工具绕过了现有的限制,并作为蛋白质蛋白的第一个生产平台,蛋白质蛋白是一种难以生产的肽和蛋白质,长度在30至300个氨基酸之间,包括富含二硫化物的候选者。Numaswitch基于双功能Switchtag蛋白,该蛋白迫使纯包涵体的高滴度表达,同时帮助蛋白质蛋白有效地重折叠为功能性蛋白质蛋白。在这里,我们展示了Numaswitch平台在含二硫化物的蛋白肽中的成功应用,如抗微生物融合肽、单链可变片段(scFv)、骆驼重链抗体片段(VHH)和人表皮生长因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Mimicking the immunosuppressive impact of fibroblasts in a 3D multicellular spheroid model Alternative therapeutics to control antimicrobial resistance: a general perspective Editorial: The boulder peptide symposium 2021 scientific update Applying artificial intelligence to accelerate and de-risk antibody discovery Editorial: Women in anti-inflammatory and immunomodulating agents: 2022
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1